Qinghai Spring Medicinal Resources Technology (600381.SH) announces a preliminary estimate of a net loss of 145 million to 174 million yuan for the year 2024.

Qinghai Spring Medicinal Resources Technology (600381.SH) announces its performance forecast for 2024, with an estimated net loss attributable to shareholders of the listed company of 145 million to 174 million RMB, and a net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses of 117 million to 146 million RMB.